StonvexLoading…
StonvexStonvexStonvexCore line items from KGS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $345.76M | $1.31B | $975.23M | $652.49M |
Operating Income | $106.81M | $340.01M | $253.12M | $188.92M |
Net Income | $17.80M | $80.52M | $55.90M | $69.91M |
EPS (Diluted) | $0.20 | $0.89 | $0.61 | $0.76 |
Total Assets | $4.49B | $4.32B | $4.37B | $4.38B |
Total Liabilities | $3.32B | $3.11B | $3.12B | $3.03B |
Cash & Equivalents | $94.36M | $3.18M | $724.00K | $5.43M |
Free Cash Flow OCF − CapEx | $-47.19M | $284.27M | $142.24M | $131.33M |
Shares Outstanding | 86.30M | 85.80M | 86.70M | 87.60M |